Santhera Pharmaceuticals Holding

Corporate brand

A specialty pharmaceutical company based in Switzerland focused on developing and commercializing innovative medicines for rare diseases, particularly neuromuscular conditions.

Last updated September 10, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Santhera is a specialty pharmaceutical company based in Switzerland committed to the development and commercialization of innovative medicines for rare diseases, specifically neuromuscular conditions. Its focus is on treatments for neuromuscular diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD). The company describes itself as a young and dynamic international pharma company whose vision is to improve the lives of people with rare diseases by delivering therapeutic options where none previously existed.

History

Santhera is a specialty pharmaceutical company based in Switzerland committed to development and commercialization of innovative medicines to meet the needs of patients living with rare diseases. The company has dedicated more than a decade to researching potential treatments for neuromuscular diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD).

Products and positioning

Specialty pharmaceutical company focused on rare diseases, specifically neuromuscular conditions with high unmet medical need.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/santhera-pharmaceuticals-holding · Editorial policy · How profiles are compiled